BALBI, MATILDE
 Distribuzione geografica
Continente #
EU - Europa 2.716
AS - Asia 287
NA - Nord America 46
SA - Sud America 38
AF - Africa 5
Totale 3.092
Nazione #
IT - Italia 2.709
SG - Singapore 115
CN - Cina 76
VN - Vietnam 65
US - Stati Uniti d'America 39
HK - Hong Kong 22
BR - Brasile 20
AR - Argentina 13
MX - Messico 4
CA - Canada 3
CO - Colombia 2
ID - Indonesia 2
IQ - Iraq 2
KE - Kenya 2
PL - Polonia 2
PT - Portogallo 2
VE - Venezuela 2
BD - Bangladesh 1
DE - Germania 1
EC - Ecuador 1
GB - Regno Unito 1
IN - India 1
KR - Corea 1
LB - Libano 1
RU - Federazione Russa 1
SN - Senegal 1
TW - Taiwan 1
YT - Mayotte 1
ZA - Sudafrica 1
Totale 3.092
Città #
Genoa 1.594
Genova 532
Vado Ligure 364
Rapallo 196
Singapore 31
Beijing 26
Ho Chi Minh City 24
Hong Kong 22
Ashburn 19
Bordighera 12
Hanoi 12
Staten Island 7
Boston 6
Haiphong 6
Da Nang 5
Tianjin 4
Mexico City 3
Montreal 3
São Paulo 3
Turin 3
Baghdad 2
Braga 2
Buenos Aires 2
Hải Dương 2
Nairobi 2
Phủ Lý 2
Wroclaw 2
Arroyo Seco 1
Basingstoke 1
Berlin 1
Biên Hòa 1
Boardman 1
Bắc Giang 1
Bắc Ninh 1
Camaragibe 1
Can Tho 1
Caucaia 1
Chicago 1
Concordia 1
Cumanacoa 1
Cumaná 1
Curitiba 1
Córdoba 1
Dakar 1
Dallas 1
Denver 1
Dhaka 1
Dongguan 1
Extrema 1
Fernandópolis 1
Formosa 1
Fortaleza 1
Fragagnano 1
Guaiçara 1
Guangzhou 1
Guaratinga 1
Ha Long 1
Hefei 1
Itabira 1
Itajaí 1
Itapeva 1
José C. Paz 1
Karnāl 1
Kennedy 1
La Plata 1
Lanzhou 1
Limeira 1
Lomas de Zamora 1
Los Angeles 1
Milagro 1
Milan 1
Moscow 1
New York 1
Nha Trang 1
Ningbo 1
Paipa 1
Pénjamo 1
Quảng Ngãi 1
Rafael Castillo 1
Ribeirão Preto 1
Rome 1
Seongbuk-gu 1
Sidon 1
São João de Meriti 1
Sóc Trăng 1
Taipei 1
Thái Bình 1
Tigre 1
Três Barras do Paraná 1
Utinga 1
Varginha 1
Verona 1
Vinh 1
Wenzhou 1
Wuhu 1
Totale 2.954
Nome #
Presynaptic GLP-1 receptors enhance the depolarization-evoked release of Glutamate and GABA in the mouse cortex and hippocampus 198
Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease. 191
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 155
Group I metabotropic glutamatergic receptors regulating glutamate release and microglia phenotype in a murine model of amyotrophic lateral sclerosis 141
GEBR-32A, A NEW PROMISING PDE4D INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE 107
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 106
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 103
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS 100
Glucagon Like Peptide-1 increases glutamate release in the mouse cerebral cortex and hippocampus by activacting presynaptic GLP-1R 99
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 97
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 93
Reducing mglur5 expression attenuates the reactive phenotype of astrocytes cultured from the spinal cord of late symptomatic SOD1G93A mice 91
Nearly 30 years of animal models to study amyotrophic lateral sclerosis: A historical overview and future perspectives. 91
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 90
cGMP MODULATES LONG-TERM POTENTIATION AND MEMORY BY ENHANCING ABETA PRODUCTION 84
In-vivo and in-vitro evidence supporting the role of mGlu5 receptor as a key regulator of glutamate downstream effects in ALS 79
Genetic and pharmacological effects by blocking mGlu5 receptor in the SOD1G93A mouse model of amyotrophic lateral sclerosis 75
Preclinical study showing a gender specific protective properties of conjugated linoleic acid (CLA) for amyotrophic lateral sclerosis 74
Phenotype changes of microglia in SOD1G93A mice after mGluR5 genetic down regulation 67
The Physio-Pathological Role of Group I Metabotropic Glutamate Receptors Expressed by Microglia in Health and Disease with a Focus on Amyotrophic Lateral Sclerosis 66
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 60
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 59
PRESYNAPTIC GLP-1 RECEPTORS ENHANCE GLUTAMATE AND GABA RELEASE FROM PURIFIED MOUSE CORTICAL AND HIPPOCAMPAL SYNAPTOSOMES 59
Multiple approaches reveal altered lipid metabolism, neurotransmitter release and nervous conduction in a zebrafish model of Alexander Disease 58
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 56
Partial deletion of mGluR5 affects M1 and M2 phenotypes in microglia acutely isolated from SOD1(G93A) mice during disease progression 55
Combined motor and behavioural tracking approach to stratify ALS progression in SOD1(G93A) mice. 54
Partial deletion of mGluR5 affects microglia inflammatory phenotype, bioenergetic characteristics, and red-ox state during ALS progression in SOD1G93A mice 51
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 48
The mGlu5 receptor negative allosteric modulator CTEP as a pharmacological tool to dampen ALS disease progression: in-vivo preclinical studies and clinical perspectives 47
Sex-specific motor and behavioural parameters for early stratification of ALS progression in SOD1(G93A) mice. 46
Changes of the microglia phenotype in the SOD1G93A mouse model of amyotrophic lateral sclerosis after mGluR5 genetic down-regulation 46
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 46
Synapto-gliosomal characterization in a zebrafish model of Alexander disease 42
MSC-derived extracellular vesicles for the treatment of ALS 41
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells revert glial activation and neurotoxicity in in-vitro models of amyotrophic lateral sclerosis 40
The partial deletion of mGluR5 affects the pro- and anti-inflammatory and bioenergetic characteristics of microglia during ALS progression in SOD1(G93A) mice 40
Phenotype changes of spinal cord microglia cells acutely purified from SOD1G93AALS mice during disease progression: focus on the genetic down regulation of mGlu5 receptor 37
Preventive effects of conjugated linoleic acid (CLA) in-vivo oral treatment in the SOD1G93A preclinical model of amyotrophic lateral sclerosis 37
Therapeutic effects of MSC-derived EVs intranasally administered on ALS mice 36
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD 36
Efficacy and Safety of Visible and Near-Infrared Photobiomodulation Therapy on Astenospermic Human Sperm: Wavelength-Dependent Regulation of Nitric Oxide Levels and Mitochondrial Energetics 28
Intranasal in-vivo administration of MSC-derived EVs on ALS mice 24
Chromosomal Deletion Involving ANKRD26 Leads to Expression of a Fusion Protein Responsible for ANKRD26-Related Thrombocytopenia 22
miR-29a-3p and TGF-β Axis in Fanconi anemia: mechanisms driving metabolic dysfunction and genome stability 22
Local Insulin for Local Needs? Insights into Retinal Insulin Signaling and RPE Metabolism 1
null 1
null 1
Totale 3.200
Categoria #
all - tutte 11.614
article - articoli 4.432
book - libri 0
conference - conferenze 6.819
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.865


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 0 0 15 11 7 6 26 11 5
2021/2022182 1 8 13 11 7 10 23 37 17 16 17 22
2022/2023245 24 20 7 19 21 28 2 22 50 6 44 2
2023/2024301 6 23 23 32 29 48 19 18 4 20 28 51
2024/20251.045 56 47 24 80 105 93 107 183 33 68 109 140
2025/20261.021 246 79 171 184 314 27 0 0 0 0 0 0
Totale 3.200